Camillo L, Pollastro F, Talmon M, Fresu L
Int J Mol Sci. 2025; 26(5).
PMID: 40076714
PMC: 11900946.
DOI: 10.3390/ijms26052092.
Chia S, Guo T, Goldys E, Payne S, Duan W, Lovell N
Bioeng Transl Med. 2025; 10(2):e10725.
PMID: 40060765
PMC: 11883116.
DOI: 10.1002/btm2.10725.
Norris L, Giroux P, Jester T, Galloway D, Maclin J, Saaybi S
Am J Case Rep. 2025; 26:e946099.
PMID: 40017015
PMC: 11877397.
DOI: 10.12659/AJCR.946099.
Carreras J, Roncador G, Hamoudi R
Cancers (Basel). 2025; 16(24.
PMID: 39766129
PMC: 11674594.
DOI: 10.3390/cancers16244230.
Wang J, An W, Wang Z, Zhao Y, Han B, Tao H
Antioxidants (Basel). 2025; 13(12.
PMID: 39765873
PMC: 11673545.
DOI: 10.3390/antiox13121544.
Harnessing 3D models to uncover the mechanisms driving infectious and inflammatory disease in the intestine.
Micati D, Hlavca S, Chan W, Abud H
BMC Biol. 2024; 22(1):300.
PMID: 39736603
PMC: 11686917.
DOI: 10.1186/s12915-024-02092-9.
Comparison of novel native probiotics and paraprobiotics in modulating oxidative stress and inflammation in DSS-induced colitis: implications for enhanced therapeutic strategies in high fat diet.
Rezaie N, Aghamohammad S, Khiavi E, Pourshafie M, Talebi M, Rohani M
BMC Immunol. 2024; 25(1):85.
PMID: 39707206
PMC: 11662435.
DOI: 10.1186/s12865-024-00678-0.
The Association Between Atopic Dermatitis and Inflammatory Bowel Disease Risk: A Meta-Analysis of Longitudinal Studies.
Yu P, Lin L, Xue K, Yang J, Wang S, An Y
JGH Open. 2024; 8(12):e70077.
PMID: 39678631
PMC: 11638360.
DOI: 10.1002/jgh3.70077.
Systemic lupus erythematosus: An imitator for inflammatory bowel disease.
Reznikov E, Person H, Davis E, Zhao Y, Otjen J, Ambartsumyan L
JPGN Rep. 2024; 5(4):514-518.
PMID: 39610413
PMC: 11600371.
DOI: 10.1002/jpr3.12126.
18F-FDG-PET and other imaging modalities in the diagnosis and management of inflammatory bowel disease.
Bhattaru A, Pundyavana A, Raynor W, Chinta S, Werner T, Alavi A
Am J Nucl Med Mol Imaging. 2024; 14(5):295-305.
PMID: 39583912
PMC: 11578808.
DOI: 10.62347/YXQT2560.
eQTL in diseased colon tissue identifies novel target genes associated with IBD.
Nishiyama N, Silverstein S, Darlington K, Kennedy Ng M, Clough K, Bauer M
bioRxiv. 2024; .
PMID: 39464142
PMC: 11507739.
DOI: 10.1101/2024.10.14.618229.
Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression.
Gorecka A, Jura-Poltorak A, Kozma E, Szeremeta A, Olczyk K, Komosinska-Vassev K
Molecules. 2024; 29(19).
PMID: 39407507
PMC: 11478261.
DOI: 10.3390/molecules29194577.
The Consumption of the Fibrous Fraction of St. Hil. Does Not Preserve the Intestinal Mucosa in TNBS-Induced Rats.
Moya A, Alexandrino T, Morari J, Reguengo L, Velloso L, Leal R
Foods. 2024; 13(18).
PMID: 39335878
PMC: 11431493.
DOI: 10.3390/foods13182949.
Bilateral Ureteral Obstruction in Children With Ulcerative Colitis and Oliguria: When and Why?.
Florou M, Diamantopoulos C, Anastasiadis K, Mouravas V, Tramma D, Tsopozidi M
Cureus. 2024; 16(8):e67031.
PMID: 39280558
PMC: 11402509.
DOI: 10.7759/cureus.67031.
Design and Synthesis of an Azo Reductase Responsive Flavonol-Indomethacin Hybrid Used for the Diagnosis and Treatment of Colitis.
Gu Y, Yang R, Chen J, Fan Y, Xie W, Wu H
Molecules. 2024; 29(17).
PMID: 39275092
PMC: 11397019.
DOI: 10.3390/molecules29174244.
Predictive value of serum markers for mucosal healing in patients with inflammatory bowel disease.
Lei L, Lv T, Wang L, Liu X
Am J Transl Res. 2024; 16(8):3723-3732.
PMID: 39262732
PMC: 11384372.
DOI: 10.62347/LXBG8588.
Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.
Walraven T, Busch M, Wang J, Donkers J, Duijvestein M, van de Steeg E
Arch Toxicol. 2024; 98(11):3519-3541.
PMID: 39249550
PMC: 11489187.
DOI: 10.1007/s00204-024-03844-w.
Use of Dietary Supplements among Polish Children with Inflammatory Bowel Disease: A Two-Center Pilot Study.
Mackow M, Koziol-Kozakowska A, Szelag M, Pytrus T, Raczkowska E, Neubauer K
Nutrients. 2024; 16(16).
PMID: 39203898
PMC: 11356985.
DOI: 10.3390/nu16162762.
Enhanced Risk of Gastroesophageal Reflux Disease and Esophageal Complications in the Ulcerative Colitis Population.
Wang X, Almetwali O, Wang J, Wright Z, Patton-Tackett E, Roy S
J Clin Med. 2024; 13(16).
PMID: 39200925
PMC: 11355171.
DOI: 10.3390/jcm13164783.
Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis.
Chen Y, Chen L, Huang S, Yang L, Wang L, Yang F
Front Genet. 2024; 15:1429482.
PMID: 39144720
PMC: 11321978.
DOI: 10.3389/fgene.2024.1429482.